Fluicell publishes 2022 Q4 Year-end report

Today, February 24 2023, Fluicell publishes the Q4 Year-end report for the period January to December, 2022. The…

Read more
24 Feb 2023

Spheroid bioprinting for disease modeling

Spheroids are a powerful tool for in vitro tissue and disease modeling, with multiple applications across cancer and…

Read more
16 Feb 2023

Fluicell is growing

Do you want to be part of an innovative team pushing the boundaries in 3D bioprinting, engineered tissue-based…

Read more
30 Jan 2023

Fluicell CEO Newsletter 05, 2022

2022 has been a busy year for us at Fluicell. Not only have we this year released Biopixlar…

Read more
20 Dec 2022

Fluicell publishes report for the third quarter 2022

Today, November 30 2022, Fluicell publishes the interim report for the period July 1 to September 30, 2022….

Read more
30 Nov 2022

Biopixlar AER Innovation of the year nomination

Biopixlar AER is nominated as Innovation of the Year for the 2022 3D Printing Industry Awards! We at…

Read more
29 Nov 2022

Biopixlar biosafety cabinet installed

Erlab-Noroit has just completed a successful installation of a customized version of their H.Box Class II biosafety cabinet,…

Read more
22 Nov 2022

Fluicell at Australian bioprinting workshop

We are happy to announce that we are attending the 4th Australian Bioprinting Workshop, taking place at Univserity…

Read more
17 Nov 2022

Fluicell welcomes Sanna Sämfors

Fluicell welcomes Sanna Sämfors who joins Fluicell as Application Specialist. In her role, Sanna will be developing bioprinting…

Read more
24 Oct 2022